$TRDA 8-K SEC Filings

Filed On	Filing
14 Oct 2026	8-K: Regulation FD Disclosure; Other Events Entrada Therapeutics Announces Positive Results from the First Cohort of Participants with Duchenne Muscular Dystrophy (DMD) in the Phase 1/2 ELEVATE-45-201 Study of ENTR-601-45
05 Aug 2026	8-K: Results of Operations and Financial Condition
10 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
19 May 2026	8-K: Regulation FD Disclosure
07 May 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
26 Feb 2026	8-K: Results of Operations and Financial Condition
08 Jan 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
06 Nov 2025	8-K: Results of Operations and Financial Condition
06 Aug 2025	8-K: Results of Operations and Financial Condition
11 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
03 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
08 May 2025	8-K: Results of Operations and Financial Condition
29 Apr 2025	8-K: Costs Associated with Exit or Disposal Activities
24 Mar 2025	8-K: Regulation FD Disclosure; Other Events
27 Feb 2025	8-K: Results of Operations and Financial Condition
24 Feb 2025	8-K: Regulation FD Disclosure; Other Events
03 Feb 2025	8-K: Regulation FD Disclosure; Other Events
15 Jan 2025	8-K: Results of Operations and Financial Condition; Other Events
05 Nov 2024	8-K: Results of Operations and Financial Condition
13 Aug 2024	8-K: Results of Operations and Financial Condition

Comments